SSLDR-A Calculated Using All Examinations Performs Similarly to Screening SSLDR-S in Predicting Post-Colonoscopy CRC
Joseph C. Anderson, MD, FACG1,2,3
1VA Medical Center, White River Junction, VT; 2Geisel School of Medicine at Dartmouth, Hanover, NH; 3University of Connecticut School of Medicine, Farmington, CT
This article reviews Hagen R, Rex DK, MacKenzie TA, Amox CI, Butterly LF, Anderson JC. Higher sessile serrated lesion detection rates calculated using all examinations are associated with lower risk for post-colonoscopy colorectal cancer: Data from the New Hampshire Colonoscopy Registry. Clin Transl Gastroenterol. 2026; 17(4).
Access the article through Clinical and Translational Gastroenterology
Keywords: serrated polyps; colonoscopy; adenomas; surveillance
STRUCTURED ABSTRACT
Question: The goal was to examine the association between post-colonoscopy colorectal cancer (PCCRC) risk and sessile serrated lesion detection rate (SSLDR) which was calculated using exams with all indications (SSLDR-A), as compared to SSLDR restricted to data from screening exams (SSLDR-S).
Design: Retrospective analysis of data from the New Hampshire Colonoscopy Registry (NHCR) which is a prospective statewide colonoscopy registry.
Setting: Endoscopy centers across New Hampshire
Patients: The analysis included NHCR patients with an index exam and at least 1 follow-up event 6 months or longer after the colonoscopy, either a colonoscopy or a CRC diagnosis.
Exposure: The exposure variable was endoscopist-specific SSLDR-A, calculated for all indications, divided into quintiles. The SSLDR-A was also compared to a SSLDR-S.
SSLDR-A= The proportion of all colonoscopies in patients 45 years or older with an adequate bowel preparation performed by an endoscopist regardless of indication with at least 1 SSL divided by the total number of colonoscopies in patients 45 years or older with an adequate bowel preparation performed by that endoscopist regardless of indications.
SSLDR-S= The proportion of screening colonoscopies in patients 45 years or older with an adequate bowel preparation performed by an endoscopist with at least one SSL divided by the total number of screening colonoscopies in patients 45 years or older with an adequate bowel preparation performed by that endoscopist.
Outcomes: The primary outcome, PCCRC was any CRC diagnosed ≥ 6 months after an index exam.
Data Analysis: Cox regression was used to model the hazard of PCCRC on ADR, controlling for age, sex, and other covariates.
Funding: Division of Cancer Prevention, National Cancer Institute, 5R01CA243449, Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling; Grant Recipient: Lynn F. Butterly, M.D. and ACG 2023 clinical research grant (Anderson).
Results: There were 177 PCCRCs diagnosed in 115,762 patients with index colonoscopies. Procedures were performed by 126 endoscopists, with at least 50 exams recorded in the NHCR. Index exams were conducted between October 2004 and December 2020. Higher SSLDR-A and SSLDR-S rates were associated with lower PCCRC risks (Table 1). After adjusting for covariates, we observed that higher SSLDR-A rates were associated with lower hazard ratios (HR) as compared to the reference group (SSLDR-A: <1.5%; HR=1.0 vs SSLDR-A: 1.5-<3.0%; HR=0.53, 95% confidence interval (CI) 0.35-0.79; SSLDR-A: 3.0-<5.0%; HR=0.59, 95% CI 0.38-0.92; SSLDR: 5.0-<8.0%; HR=0.44, 95% CI 0.28-0.70; and SSLDR:8.0+% HR=0.20, 95% CI 0.08-0.46). The highest quintile of SSLDR-A (8.0%+) (HR=0.20, 95%CI 0.08-0.46) and SSLDR-S (8.0%+)(HR=0.20, 95% CI 0.09-0.44) provided similar protection from PCCRC. The 95% CI was narrower (median= 73%; IQR:0.09) for endoscopists when calculating SSLDR-A versus SSLDR-S. In contrast, when calculating the 95% CI for SSLDR-S compared to SSLDR-A, the CI increased nearly two-fold (median=137%; IQR 0.17).
Table 1. Unadjusted risks and adjusted hazard ratios for post-colonoscopy colorectal cancer for quintiles of endoscopist SSLDR-S and SSLDR-A. HR, hazard ratio; SSLDR-A, all-examination sessile serrated lesion detection rates; SSLDR-S, screening sessile serrated lesion detection rate.
a P<0.001 (X2 for trend).
COMMENTARY
Why Is This Important?
The detection and resection of precancerous polyps is important for colonoscopy to be effective in CRC prevention. Endoscopists have been monitoring their adenoma detection rates (ADR), which have been shown to be inversely associated with post-colonoscopy colorectal cancer (PCCRC) incidence.1, 2 Recent recommendations from the joint American College of Gastroenterology (ACG)/American Society of Gastrointestinal Endoscopy (ASGE) task force suggest that ADR can be calculated using data from all exams.3-6 Using data from examinations using all indications (ADR-A), rather than screening exams alone (ADR-S), can be beneficial by allowing a larger sample size, which may provide a more accurate assessment of an endoscopist’s overall performance. It can also mitigate potential gaming by endoscopists to manipulate their metrics.7
Serrated polyp detection is also crucial for CRC prevention since the serrated pathway may account for up to one-third of all CRCs and a large percentage of post-colonoscopy cancers. Serrated polyps include hyperplastic polyps (HPs), sessile serrated lesions, and traditional serrated adenomas of any size. New Hampshire Colonoscopy Registry data suggest that even if endoscopists achieve an adequate ADR, they could still have a low serrated detection rate.8-10 Therefore SSLDRs should be tracked by endoscopists. Sessile serrated lesion detection rate for screening exams (SSLDR-S) is defined as the number of screening colonoscopies with at least one SSL divided by the total number of screening colonoscopies for each endoscopist. An analysis of NHCR data suggests that a SSLDR-S of 6% may offer the most protection from PCCRC.10
As with ADR-A, a major advantage of using SSLDR-A (sessile serrated lesion detection rate using all exams) is its inclusion of all colonoscopies, regardless of the indication. This approach simplifies calculations by removing the need to distinguish between exam types, which in turn reduces endoscopist-level biases and prevents potential misclassification based on the reason for the exam. Furthermore, incorporating all colonoscopies increases the total sample size, resulting in higher statistical power, generalizability, and a noticeably narrower confidence interval as observed in this analysis, reflecting greater data precision and lower variability.
Key Study Findings
Caution
The low racial diversity in NH may decrease the generalizability of the findings. Thus, more data are needed in other more racially diverse populations.
My Practice
An important factor in optimizing serrated detection is the bowel preparation. All of my patients have a split bowel preparation.11 When performing a colonoscopy, I make the assumption that the patient has an SSL that I should be detecting. Thus, during inspection I carefully interrogate and wash every fold, adequately distending the lumen, utilizing an adequate withdrawal time, typically of 8 minutes or longer. I also re-intubate the proximal colon as highlighted in the recent ACG/ASGE recommendations.6, 12 In our endoscopy unit we track our ADR and SSLDRs as well as quality of bowel preparation and completion rates, ensuring that we are meeting established benchmarks.6, 11, 12 Although, current benchmark as per the recent ACG/ASGE latest recommendations on quality indicators for colonoscopy is 6%, I try to achieve an SSLDR-A of 8% or greater.
For Future Research
These data should be validated in other populations.
Conflict of Interest
Dr Anderson has no financial conflict of interest.
REFERENCES
- Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298–306.
- Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology 2017;153:98–105.
- Anderson JC, Rex DK, Mackenzie TA, et al. Endoscopist adenomas-per-colonoscopy detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2024;99:787–795.
- Anderson JC, Rex DK, Mackenzie TA, et al. Adenoma detection rates calculated using all examinations are associated with lower risk for postcolonoscopy colorectal cancer: Data from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 2025.
- Anderson JC, Weiss JE, Robinson CM, et al. Adenoma detection rates for screening colonoscopies in smokers and obese adults: Data from the New Hampshire Colonoscopy Registry. J Clin Gastroenterol 2017;51:e95–e100.
- Rex DK, Anderson JC, Butterly LF, et al. Quality indicators for colonoscopy. Am J Gastroenterol 2024;119:1754–1780.
- Rex DK, Ponugoti PL. Calculating the adenoma detection rate in screening colonoscopies only: Is it necessary? Can it be gamed? Endoscopy 2017;49:1069–1074.
- Anderson JC, Butterly LF, Weiss JE, et al. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2017;85:1188–1194.
- Anderson JC, Hisey W, Mackenzie TA, et al. Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc 2022;96:310–317.
- Anderson JC, Rex DK, Mackenzie TA, et al. Higher serrated polyp detection rates are associated with lower risk of postcolonoscopy colorectal cancer: Data from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 2023;118:1927–1930.
- Jacobson BC, Anderson JC, Burke CA, et al. Optimizing bowel preparation quality for colonoscopy: Consensus recommendations by the US Multi-Society Task Force on colorectal cancer. Am J Gastroenterol 2025;120:738–764.
- Anderson JC, Rex DK. Performing high-auality, safe, cost-effective, and efficient basic colonoscopy in 2023: Advice from two experts. Am J Gastroenterol 2023;118:1779–1786.

